LIVESURE BENZODIAZEPINES SCREEN TESTS— 510(k) K012131

Name: FDA 510(k) clearance K012131
Creator: U.S. Food and Drug Administration
Published: 2001-07-20

Substantially Equivalent

Pan Probe Biotech, Inc.

FDA 510(k) clearance K012131 for LIVESURE BENZODIAZEPINES SCREEN TESTS, Substantially Equivalent on 2001-07-20. Applicant: Pan Probe Biotech, Inc.. Device class: 2.

Clearance details

Applicant: Pan Probe Biotech, Inc.
Product code: Code JXM
Device class: Class 2
Regulation: 21 CFR 862.3170
Advisory panel: Clinical Toxicology
Date received: 2001-07-09
Decision date: 2001-07-20
Decision: Substantially Equivalent
Clearance type: Traditional
Location: San Diego, CA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code JXM

view all

K243498 — Alinity c Benzodiazepines Reagent Kit2024-12-11
K221765 — ONLINE DAT Benzodiazepines II2022-12-23
K190968 — CEDIA Benzodiazepine Assay2019-12-09
K173963 — DRI Benzodiazepine Assay2018-02-21
K163590 — Psychemedics Microplate EIA for Benzodiazepines in Hair2017-09-15

More clearances from Pan Probe Biotech, Inc.

view all

K020968 — LIVESURE HCG URINARY PREGNANCY TEST STRIP AND TEST CARD2002-07-15
K013796 — LIVESURE METHADONE SCREEN TESTS2001-11-26
K012107 — LIVESURE PHENECYCLINE (PCP) SCREEN TESTS2001-07-20
K012133 — LIVESURE BARBITURATES SCREEN TEST2001-07-20
K011609 — LIVESURE AMPHETAMINE SCREEN TEST2001-06-08

Data sourced from openFDA. This site is unofficial and independent of the FDA.